BioSpace13d
The Top 7 Biopharma Licensing Deals of 2024
Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...
GVB Biopharma Launches State-of-the-Art Isolation Facility with Over 300,000-Kilo Annual Production Capacity
GVB Biopharma, the largest global producer of cannabinoids, is proud to announce the launch of its cutting-edge isolation facility, marking a significant leap in production capabilities and efficiency ...
Pharm Exec5d
Biopharma Business Check: Financing Review and Outlook
A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and ...
Alnylam Pharmaceuticals’ (ALNY) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report report published on Friday morning,Benzinga reports. They ...
Business Wire5d
Prolific Machines Announces the Appointment of Former Forge Biologics Executive, Christina Perry, as CFO Setting the Stage for Optogenetics Leader’s Biopharmaceutical ...
The Bay Area company enables biopharmaceutical and biotechnology companies of all stages to solve complex protein challenges; light-enabled gene expression control enables the production of ...